MarkWide Research

Sale!

Digital Pathology Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: August, 2022
No of Pages: 155
Delivery Format: PDF + Excel

$2,950.00

The global digital pathology market was worth USD 926.9 Million in 2021. It is expected to grow at a compound annual rate (CAGR of 7.5%) between 2022 and 2030. The market has been driven by a greater focus on workflow efficiency and demand for quicker diagnostic tools for chronic diseases such as cancer. Digital pathology will be more in demand due to the rising incidence of chronic conditions. This will increase the clinical urgency to adopt digital pathology. It will improve existing diagnostic imaging methods for patients and reduce the high costs associated with traditional diagnostics. The demand for advanced diagnostic technologies will also increase due to the growing number of elderly patients susceptible to chronic diseases.

MWR published a study that found chronic diseases could be linked to high mortality rates. It is imperative that advanced imaging and diagnostic options are used due to the high incidence of Cardiovascular Diseases (CVDs). The new coronavirus has a major economic impact on all sectors, including healthcare. To reduce the spread of COVID-19, governments around the globe are taking essential steps to address the problem. These include large-scale quarantine and social distancing as well as national lockdowns. Digital pathology saw a significant growth opportunity due to the pandemic.

CMS temporarily lifted the strict regulation governing remote diagnosis and permitted remote sign-outs of pathology cases using digital equipment. The U.S. FDA’s Center for Devices and Radiological Health issued an enforcement policy for remote pathology devices for healthcare professionals, pathologists, and industry. This policy framework provides guidelines for expanding the availability of remote pathology devices during the pandemic. In the next few years, supportive regulations will positively impact the market.

Product Insights

In 2021, the device segment was the dominant market and earned the highest revenue share at 52.0%. This segment also includes slide management systems and scanners. The key growth drivers for this segment are increased adoption in academic research and improved resolution. The technology will see significant growth in the future due to advances in magnification, scanning slides at the Z-axis, and whole slide imaging. Its usage will be boosted by intuitive user interfaces, high bandwidth connectivity, and other improvements. Major players are constantly improving digital pathology scanners.

OptraSCAN introduced the OS-Ultra 320 high-speed scanners in April 2021. This scanner can scan tissue and cells up to 15x15mm in size at 40x magnification in 60 seconds. Market growth is also driven by the increased use of scanners within pathology labs. Shortly, slide managers will be more popular due to increased R&D. Market growth is also driven by the growing demand for online storage systems. Market growth is expected to be driven by the benefits such as cost reduction, better productivity, and better patient outcomes, along with data reliability, image life cycle management, and data reliability.

Application Insights

Academic research applications accounted for more than 45.5% of global revenue in 2021. This segment is expected to grow at a steady CAGR of 3% between 2022 and 2030. This high share can be attributed to the increased use of digital pathology in research studies such as tumour morphological analysis. The academic research segment will be further impacted by introducing many cancer therapies shortly. The market can be divided into hospitals, diagnostic laboratories, biotech & pharmaceutical companies, academic and research institutes, and others.

Over the forecast period, the diagnosis segment will experience the highest CAGR. This is due to the increasing prevalence of chronic illnesses. Manufacturers are investing heavily in the development of rapid and novel diagnostic methods. This will also help to grow the diagnostics segment. Digital technologies can improve each step of diagnostics. Over the forecast period, the cancer cell detection sub-segment will also significantly increase disease diagnosis. This is due to the high incidence of the disease and ongoing research efforts.

End-use Information

The market can be divided into four segments based on end-use: hospitals, diagnostic laboratories, biotech and pharmaceutical companies, academic and research institutions, and hospitals. In 2021, the hospital’s segment had a greater revenue share than 36%. This was due to the high adoption of digital scanning techniques within hospitals to speed up diagnosis and improve patient compliance. Mackenzie Health and Philips partnered in August 2020 to create Canada’s first digital pathology platform. This platform allows for quicker diagnosis and better treatment. With the introduction of Philips’ IntelliSite pathology platform, the hospital hopes to improve laboratory efficiency, access to specialists and speed up diagnosis.

These collaborations will also be expected to drive the segment’s growth. The diagnostic lab segment, on the other hand, is expected to experience the fastest CAGR between 2022 and 2030. Over the forecast period, the biotechnology and pharmaceutical companies segment is expected to experience steady growth. This is due to increased digital pathology being used in drug development, clinical trials in oncology, and preclinical GLP Pathology. This segment is further supported by a rise in cancer prevalence and high demand for better treatments.

Regional Insights

North America had a greater revenue share than 41% in 2021. The key drivers of the market are:

  • Continuous R&D investments.
  • Government support initiatives for the development of technologically advanced systems.
  • Growing adoption of digital imaging and the presence of major players.

The regional market will continue to grow due to the increased use of digital pathology in disease diagnosis and favourable reimbursement policies in the U.S. that improve the quality of cancer diagnosis. The fastest expected CAGR for the Asia Pacific will be observed during the forecast period.

This growth can be attributed largely to digital imaging’s increasing penetration in emerging economies, investments in the medical sector, and untapped opportunities in the Asia Pacific. Due to rising incidences of cancer in the Asia Pacific, the healthcare industry has significantly impacted the market. Market growth is expected to be driven by rising demand for innovative treatment options, improved patient care facilities, and a decrease in laboratory costs.

Key Companies & Market share Insights

In 2021, major players like Hamamatsu Photonics, Inc. and Danaher held the dominant market share. To increase their market share, these companies are increasingly pursuing strategies such as new product development and extensive collaborative strategies. Paige’s AI-enabled research software was integrated with Leica Biosystems’ digital pathology platform. This partnership took place in April 2021. This would allow for greater access to computational pathology products in North America and Europe selected countries. Philips and Ibex Medical Analytics partnered in April 2021 to combine their digital pathology solutions with Ibex’s AI-powered Galen platform. This will enhance the company’s offerings. Philips helped Oxford University Hospitals Cellular Pathology complete the digitization of all histology slides. The following are some of the most prominent players in the global market for digital pathology:

  • Leica Biosystems (Danaher)
  • Objective Pathology
  • Glencoe Software
  • Corista
  • Apollo Enterprise imaging
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies
  • Inspirata, Inc.
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Huron Technologies International, Inc.
  • ContextVision AB

Digital Pathology Market Report Scope

Report AttributeDetails
Market size in 2022USD 975.5 Million
Forecast revenue for 2030USD 1.74 Billion
Rate of growthCAGR of 7.5% between 2022 and 2030
Estimation base year2021
Historical data2017 – 2021
Forecast period2022 – 2030
Quantitative unitsFrom 2022 to 2030, revenue in USD millions/billion and CAGR
Report coverageForecast revenue, company ranking and competitive landscape, growth factors and trends
Segments coveredRegion, product, application, end use
Regional scopeNorth America; Europe; Asia Pacific, Latin America; MiddleEast; Africa
Country coverageU.S., Canada; Germany, France; Italy. Spain; Russia; The Netherlands. Sweden. Japan. India. China. Indonesia. Thailand. Australia. South Korea. Philippines. Singapore. Brazil. Argentina. Mexico. South Africa. Saudi Arabia. Turkey. Iran.
Key companies profiledLeica Biosystems (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.; F. Hoffmann-La Roche Ltd.; Mikroscan Technologies; Inspirata, Inc.; 3DHISTECH Ltd.; Visiopharm A/S; Huron Technologies International, Inc.; ContextVision AB, Objective Pathology,Glencoe Software, Corista, Apollo Enterprise imaging

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2017 to 2030. MarkWide Research has divided the global market for digital pathology on the basis product, region, application, and end-use.

  • Product Outlook 
    • Software
    • Device
      • Scanners
      • Slide Management System
    • Storage System
  • Application Outlook 
    • Drug Discovery & Development
    • Academic Research
    • Diagnosis of Disease
      • Cancer Cell Detection
      • Other
  • End-use Outlook 
    • Hospitals
    • Biotech & Pharma Companies
    • Diagnostic Labs
    • Academic & Research Institutes
  • Regional Analysis
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • Italy
      • France
      • UK
      • Spain
      • Poland
      • Russia
      • The Netherlands
      • Norway
      • Czech Republic
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Indonesia
      • Malaysia
      • Thailand
      • Singapore
      • Australia & New Zealand
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Colombia
      • Rest of South America
    • The Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Northern Africa
      • Rest of MEA

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 MWR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Workflow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Primary Sources
1.8 List Of Secondary Sources
1.9 List Of Abbreviations
1.10 Market Definitions
1.11 Report Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.1.1 Digital Pathology Market Outlook, 2017 – 2030 (USD Million)
2.2 Digital Pathology Market Summary, 2021
2.3 Segment Outlook
2.4 Competitive Insights
Chapter 3 Digital Pathology Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List Of Potential Customers
3.5 Regulatory Framework
3.5.1 List Of Regulations
3.6 Political Landscape, Current & Future Scenario
3.6.1 List Of Regulations
3.6.1.1 The Health Insurance Portability And Accountability (HIPAA)
3.6.1.2 The Clinical Laboratory Improvement Amendments (CLIA)
3.7 Digital Pathology Market Dynamics
3.7.1 Market Driver Analysis
3.7.2 Increasing Prevalence Of Chronic Diseases
3.7.3 Higher Cost-Efficiency
3.7.4 Rapid Technological Advancement
3.7.5 Market Restraint Analysis
3.7.6 Lack Of Reimbursement For Digital Pathology-Enabled Services
3.7.7 Industry Challenges
3.8 Digital Pathology Market Analysis Tools: Porters
3.9 Swot Analysis By Factors (Political & Legal, Economic, Social And Technology)
3.10 Cost Structure Analysis
3.10.1 Price Erosion Analysis
Chapter 4 Digital Pathology Market Competitive & Vendor Landscape
4.1 Participation Categorization
4.2 Strategic Initiative & Outcome Analysis
4.2.1 Key Strategies, By Company
4.3 Estimated Company Market Share Analysis, 2021
4.4 Vendor Landscape
4.4.1 List Of Distributors
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.5.2 Market Differentiators
4.6 Private Companies
4.6.1 Company Market Position Analysis
4.6.2 Regional Network Map
4.6.3 List Of Emerging Companies
4.7 Major Deals And Strategic Alliances Analysis
4.8 Case Study
Chapter 5 Digital Pathology Market: Impact Of Covid-19
5.1 Current And Future Impact Analysis
5.2 Opportunity Analysis
Chapter 6 Digital Pathology Market: Product Estimates & Trend Analysis
6.1 Market: Product Movement Analysis
6.2 Software
6.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.3 Device
6.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.3.2 Scanners
6.3.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.3.3 Slide Management System
6.3.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.4 Storage System
6.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 7 Digital Pathology Market: Application Estimates & Trend Analysis
7.1 Market: Application Movement Analysis
7.2 Drug Discovery & Development
7.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3 Academic Research
7.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4 Disease Diagnosis
7.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.2 Cancer Cell Detection
7.4.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.3 Other Applications
7.4.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 8 Digital Pathology Market: End-use Estimates & Trend Analysis
8.1 Market: End-Use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.3 Biotechnology & Pharmaceutical Companies
8.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4 Diagnostic Laboratories
8.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5 Academic And Research Institutes
8.5.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 9 Pathology Market: Regional Estimates & Trend Analysis, By Product, Application, End Use
9.1 Market Shares By Region, 2021 & 2030
9.2 North America
9.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.2.3 Canada
9.2.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3 Europe
9.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.2 U.K.
9.3.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.3 Germany
9.3.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.4 France
9.3.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.5 Italy
9.3.5.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.6 Russia
9.3.6.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.7 Spain
9.3.7.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.8 The Netherland
9.3.8.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.9 Switzerland
9.3.9.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.3.10 Sweden
9.3.10.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.3 China
9.4.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.4 India
9.4.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.5 Indonesia
9.4.5.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.6 Thailand
9.4.6.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.7 Australia
9.4.7.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.8 South Korea
9.4.8.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.9 Philippines
9.4.9.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.10 Malaysia
9.4.10.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.4.11 Singapore
9.4.11.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.5 Latin America
9.5.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.5.2 Mexico
9.5.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.5.3 Brazil
9.5.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.5.4 Argentina
9.5.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6 MEA
9.6.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.4 Turkey
9.6.4.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.5 Iran
9.6.5.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.6 United Arab Emirates
9.6.6.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
9.6.7 Israel
9.6.7.1 Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 10 Company Profiles
10.1 Danaher
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiative
10.2 Hamamatsu Photonics, Inc
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.2.4 Strategic Initiative
10.3 Koninklijke Philips N.V.
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiative
10.4 Olympus Corporation
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiative
10.5 F. Hoffmann-La Roche Ltd
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiative
10.6 Mikroscan Technologies
10.6.1 Company Overview
10.6.2 Product Benchmarking
10.6.3 Strategic Initiative
10.7 Inspirata, Inc
10.7.1 Company Overview
10.7.2 Product Benchmarking
10.8 Visiopharm A/S
10.8.1 Company Overview
10.8.2 Product Benchmarking
10.8.3 Strategic Initiative
10.9 Huron Digital Pathology
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiative
10.10 3DHISTECH Ltd
10.10.1 Company Overview
10.10.2 Product Benchmarking
10.10.3 Strategic Initiative
10.11 ContextVision AB
10.11.1 Company Overview
10.11.2 Product Benchmarking
10.11.3 Strategic Initiative
Chapter 11 Key Opinion Leader (KOL) Commentary
Chapter 12 Recommendations

 

List of Tables

Table 1 List of Abbreviations
Table 2 Table 2 List of distributors
Table 3 Table 3 List of emerging companies
Table 4 North America Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 5 North America Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 6 North America Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 7 U.S. Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 8 U.S. Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 9 U.S. Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 10 Canada Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 11 Canada Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 12 Canada Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 13 Europe Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 14 Europe Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 15 Europe Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 16 U.K. Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 17 U.K. Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 18 U.K. Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 19 Germany Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 20 Germany Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 21 Germany Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 22 France Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 23 France Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 24 France Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 25 Italy Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 26 Italy Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 27 Italy Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 28 Spain Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 29 Spain Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 30 Spain Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 31 Russia Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 32 Russia Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 33 Russia Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 34 The Netherlands Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 35 The Netherlands Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 36 The Netherlands Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 37 Switzerland Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 38 Switzerland Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 39 Switzerland Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 40 Sweden Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 41 Sweden Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 42 Sweden Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 43 Asia Pacific Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 44 Asia Pacific Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 45 Asia Pacific Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 46 Japan Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 47 Japan Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 48 Japan Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 49 China Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 50 China Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 51 China Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 52 India Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 53 India Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 54 India Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 55 Indonesia Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 56 Indonesia Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 57 Indonesia Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 58 Thailand Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 59 Thailand Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 60 Thailand Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 61 Australia Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 62 Australia Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 63 Australia Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 64 South Korea Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 65 South Korea Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 66 South Korea Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 67 Philippines Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 68 Philippines Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 69 Philippines Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 70 Malaysia Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 71 Malaysia Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 72 Malaysia Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 73 Singapore Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 74 SingaporeDigital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 75 Singapore Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million).
Table 76 Latin America Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 77 Latin America Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 78 Brazil Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 79 Brazil Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 80 Brazil Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 81 Mexico Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 82 Mexico Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 83 Mexico Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 84 Argentina Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 85 Argentina Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 86 Argentina Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million
Table 87 MEA Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 88 MEA Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 89 MEA Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 90 South Africa Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 91 South Africa Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 92 South Africa Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 93 Saudi Arabia Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 94 Saudi Arabia Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 95 Saudi Arabia Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 96 Turkey Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 97 Turkey Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 98 Turkey Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 99 Iran Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 100 Iran Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 101 Iran Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 102 United Arab Emirates Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 103 United Arab Emirates Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 104 United Arab Emirates Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)
Table 105 Israel Digital Pathology market estimates and forecasts, by Product, 2017 – 2030 (USD Million)
Table 106 Israel Digital Pathology market estimates and forecasts, by Application, 2017 – 2030 (USD Million)
Table 107 Israel Digital Pathology market estimates and forecasts, by End Use, 2017 – 2030 (USD Million)

 

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity workflow analysis
Fig. 10 Volume price analysis
Fig. 11 Digital pathology market revenue, 2017-2030 (USD Million)
Fig. 12 Digital pathology market snapshot
Fig. 13 Competitive insights
Fig. 14 Parent market outlook
Fig. 15 Ancillary Market Outlook
Fig. 16 Penetration & growth prospect mapping
Fig. 17 Consumer behaviour analysis
Fig. 18 Parameters considered by buyers for selecting digital pathology solutions
Fig. 19 Market influencer analysis
Fig. 20 Digital pathology market dynamics
Fig. 21 Digital pathology market driver impact
Fig. 22 Digital pathology market restraint impact
Fig. 23 Digital pathology market: Porter’s five forces analysis
Fig. 24 SWOT Analysis, By Factor (Political & legal, economic and technological)
Fig. 25 Market Participant Categorization
Fig. 26 Key Companies and strategies
Fig. 27 Company Market Share Analysis, 2021
Fig. 28 Company market position analysis
Fig. 29 Market differentiators
Fig. 30 Company market position analysis
Fig. 31 Regional network map
Fig. 32 Strategy mapping
Fig. 33 Digital Pathology: Case Study
Fig. 34 Digital pathology market product outlook: Key takeaways
Fig. 35 Digital Pathology market: Product movement analysis
Fig. 36 Global software market, 2017 – 2030 (USD Million)
Fig. 37 Global device market, 2017 – 2030 (USD Million)
Fig. 38 Global scanners market, 2017 – 2030 (USD Million)
Fig. 39 Global slide management system market, 2017 – 2030 (USD Million)
Fig. 40 Global storage system market, 2017 – 2030 (USD Million)
Fig. 41 Digital pathology market: Application movement analysis
Fig. 42 Digital pathology market application outlook: Key takeaways
Fig. 43 Global drug discovery & development market, 2017 – 2030 (USD Million)
Fig. 44 Global academic research market, 2017 – 2030 (USD Million)
Fig. 45 Global disease diagnosis market, 2017 – 2030 (USD Million)
Fig. 46 Global cancer cell detection market, 2017 – 2030 (USD Million)
Fig. 47 Global other applications market, 2017 – 2030 (USD Million)
Fig. 48 Digital pathology market End Use outlook: Key takeaways
Fig. 49 Digital pathology market: End Use movement analysis
Fig. 50 Global hospitals market, 2017 – 2030 (USD Million
Fig. 51 Global biotechnology & pharmaceutical companies’ market, 2017 – 2030 (USD Million)
Fig. 52 Global diagnostic laboratories market, 2017 – 2030 (USD Million
Fig. 53 Global academic and research institutes market, 2017 – 2030 (USD Million)
Fig. 54 Regional market place: Key takeaways
Fig. 55 Regional outlook, 2021 & 2030
Fig. 56 North America digital pathology market, 2017 – 2030 (USD Million)
Fig. 57 U.S. digital pathology market, 2017 – 2030 (USD Million)
Fig. 58 Canada digital pathology market, 2017 – 2030 (USD Million)
Fig. 59 Europe digital pathology market, 2017 – 2030 (USD Million)
Fig. 60 U.K digital pathology market, 2017 – 2030 (USD Million)
Fig. 61 Germany digital pathology market, 2017 – 2030 (USD Million)
Fig. 62 France digital pathology market, 2017 – 2030 (USD Million)
Fig. 63 Italy digital pathology market, 2017 – 2030 (USD Million)
Fig. 64 Russia digital pathology market, 2017 – 2030 (USD Million)
Fig. 65 Spain digital pathology market, 2017 – 2030 (USD Million)
Fig. 66 The Netherlands digital pathology market, 2017 – 2030 (USD Million)
Fig. 67 Switzerland digital pathology market, 2017 – 2030 (USD Million)
Fig. 68 Sweden digital pathology market, 2017 – 2030 (USD Million)
Fig. 69 Asia Pacific digital pathology market, 2017 – 2030 (USD Million)
Fig. 70 Japan digital pathology market, 2017 – 2030 (USD Million)
Fig. 71 China digital pathology market, 2017 – 2030 (USD Million)
Fig. 72 India digital pathology market, 2017 – 2030 (USD Million)
Fig. 73 Indonesia digital pathology market, 2017 – 2030 (USD Million)
Fig. 74 Thailand digital pathology market, 2017 – 2030 (USD Million)
Fig. 75 Australia digital pathology market, 2017 – 2030 (USD Million)
Fig. 76 South Korea digital pathology market, 2017 – 2030 (USD Million)
Fig. 77 Philippines digital pathology market, 2017 – 2030 (USD Million)
Fig. 78 Malaysia digital pathology market, 2017 – 2030 (USD Million)
Fig. 79 Singapore digital pathology market, 2017 – 2030 (USD Million)
Fig. 80 Latin America digital pathology market, 2017 – 2030 (USD Million)
Fig. 81 Mexico digital pathology market, 2017 – 2030 (USD Million)
Fig. 82 Brazil digital pathology market, 2017 – 2030 (USD Million)
Fig. 83 Argentina digital pathology market, 2017 – 2030 (USD Million)
Fig. 84 MEA digital pathology market, 2017 – 2030 (USD Million)
Fig. 85 South Africa digital pathology market, 2017 – 2030 (USD Million)
Fig. 86 Saudi Arabia digital pathology market, 2017 – 2030 (USD Million)
Fig. 87 Turkey digital pathology market, 2017 – 2030 (USD Million)
Fig. 88 Iran digital pathology market, 2017 – 2030 (USD Million)
Fig. 89 United Arab Emirates digital pathology market, 2017 – 2030 (USD Million)
Fig. 90 Israel digital pathology market, 2017 – 2030 (USD Million)

Segmentation

  • Product Outlook 
    • Software
    • Device
      • Scanners
      • Slide Management System
    • Storage System
  • Application Outlook 
    • Drug Discovery & Development
    • Academic Research
    • Diagnosis of Disease
      • Cancer Cell Detection
      • Other
  • End-use Outlook 
    • Hospitals
    • Biotech & Pharma Companies
    • Diagnostic Labs
    • Academic & Research Institutes

Major Companies

  • Leica Biosystems (Danaher)
  • Objective Pathology
  • Glencoe Software
  • Corista
  • Apollo Enterprise imaging
  • Hamamatsu Photonics, Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • Mikroscan Technologies
  • Inspirata, Inc.
  • 3DHISTECH Ltd.
  • Visiopharm A/S
  • Huron Technologies International, Inc.
  • ContextVision AB
  • Others

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF